Christine Blank
New diabetes drug set to rival Trulicity
If it is approved by FDA, an investigational drug to improve glycemic control in patients with type 2 diabetes will likely be a strong competitor to Eli Lilly’s dulaglutide (Trulicity).
Shingles vaccine wins approval
FDA approved the herpes zoster vaccine (Shingrix, GlaxoSmithKline) to treat shingles in adults aged 50 years and older.
ISMP issues insulin pen warning after patient death
More education is needed for diabetic patients after a patient died from incorrectly using an insulin pen, according to a new warning from the Institute for Safe Medication Practices.
Drug shortages likely after hurricanes
FDA Commissioner Scott Gottlieb, MD, said that the United States is likely to see shortages on certain drugs because after Hurricanes Irma and Maria knocked out power to the islands.
FDA: Risk of blindness from compounded eye drug
FDA warns that this compounded eye drug could lead to a disease that causes blindness.
Novel device helps diabetics avoid stress linked to glucose testing
FDA approved the first continuous glucose monitoring system that allows for diabetes treatment decisions without requiring a fingerstick.
New drug offers hope to advanced breast cancer patients
FDA approved a new treatment for certain breast cancer patients who are not responding to treatment.
FDA approves generic Tamiflu, plus 2 other new drugs
FDA approves generic Tamiflu, plus 2 other new drugs
FDA approved the first generic version of oseltamivir phosphate (Tamiflu, Roche) for oral suspension to treat influenza A and B, plus 2 other noteworthy therapies.
Cholesterol drug misbranded, company pleads guilty
Cholesterol drug misbranded, company pleads guilty
Pharma maker pleads guilty that one of its major drugs was misbranded in a federal court case brought by FDA and the US Department of Justice.